On December 13, 2024, MEDIROM Healthcare Technologies Inc. announced that its subsidiary, MEDIROM MOTHER Labs Inc., has raised an aggregate total of JPY 260.3 million, approximately USD $1.7 million, in its Series A equity financing round.
The financing was conducted at a pre-money equity valuation of JPY 9 billion, approximately USD $58.6 million. NFES Technologies Inc. served as the lead investor, with participation from several public companies in Japan, including M3, Inc. and Elematec Corporation, as well as individual investors.
This successful fundraising round, which is still ongoing and expected to conclude by December 31, 2024, provides significant validation for Mother Labs' technology and business model. The involvement of multiple strategic partners is expected to support the commercialization of products like the MOTHER Bracelet and the Lav health application.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.